Advertisement

Topics

Partnership Programs for Reducing Cardiovascular Disparities in Native Hawaiians

2014-08-27 03:53:44 | BioPortfolio

Summary

The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities in Hawaii.

Description

BACKGROUND:

While there has been great progress in reducing CVD morbidity and mortality in the U.S. over the past 40 years, some minority groups have not benefitted from this progress, and continue to have lower life expectancy and higher CVD morbidity. On average, minorities have more limited access to medical care, receive less aggressive care, and receive fewer diagnostic and therapeutic cardiac procedures than non-minority populations. Additionally, most minority groups adhere poorly to prescribed medical regimens and often present to emergency departments rather than primary care physicians for complications of advanced chronic CVD conditions. Thus, research to reduce health disparities by improving CVD outcomes in minorities offers potential for a substantial positive impact on public health. Academic medical centers and institutions that are capable of carrying out such research, however, often lack access to minority patients and have difficulty gaining the trust of those they are able to treat. Minority communities often report greater satisfaction when receiving care from minority providers and are reluctant to receive treatment outside their minority healthcare serving systems.

In general, minorities have high rates of elevated cholesterol, hypertension, cigarette smoking, obesity, metabolic syndrome, and diabetes. Other behavioral, environmental, and occupational risk factors for cardiovascular diseases, such as sleep problems are also common among minorties. These risk factors all contribute to excess CVD morbidity and mortality. Heart failure (HF) is also a major public health problem. The impact of HF on minority populations, such as Native Hawaiians and other Pacific peoples, is unknown. Native Hawaiians are known to have high rates of risk factors for HF and one of the highest rates of CVD mortality in the U.S. The causes of minority health disparities are complex and are not understood completely. Although evidence of genetic, biologic, and environmental factors is well documented, poor outcomes are also attributed to incomplete treatment. Such treatment may be due to limited access to health care or, in some cases, break-down of the medical system or failure of the physician and/or patient to allow for optimal health care, even when access is not impaired. The complex interactions of behavior, socio-economic status (SES), culture, and ethnicity are important predictors of health outcomes and sources of health disparities. Despite efforts to elucidate genetic and environmental risk factors and to promote cardiovascular health in high-risk populations, trends in CVD outcomes suggest that CVD health disparities continue to widen.

The Partnerships Program to Reduce Cardiovascular Health Disparities involves collaboration between research-intensive medical centers (RIMCs) that have a track record of NIH-supported research and patient care and minority healthcare serving systems (MSSs) that lack a strong research program. Each Partnership Program will design and carry out multiple interdisciplinary research projects that investigate complex biologic, behavioral, and societal factors that contribute to CVD health disparities and facilitate clinical research within the MSS. The aim will be to improve CVD outcomes and reduce health disparities. Additionally, each program will provide reciprocal educational and skills development programs to train investigators to conduct research that is aimed at reducing cardiovascular disparities, thereby enhancing research opportunities and enriching cultural sensitivity and cardiovascular research capabilities at both institutions.

The Request for Applications for Partnership Programs to Reduce Cardiovascular Disparities was released in September, 2003. The awards were made in September, 2004.

DESIGN NARRATIVE:

To address heart failure disparities among native Hawaiians and Pacific peoples, a partnership program, the HF Disparities Program (HFD), will be established between the Queen Emma Clinic (QEC) and the Department of Native Hawaiian Health. Partners of the HFD Program include tha following: MedStar Research Institute, Oahu-based Community Health Centers (CHCs), and the Hawaii EXPORT Center, an NIH-funded initiative addressing diabetes-associated disparities in native Hawaiians and Pacific peoples. The HFD Program will address the following aims: determine the reliability and validity of echocardiograms performed by community-based health workers compared to a professionally trained sonographer as the "gold standard"; determine if a culturally competent educational program for heart failure reduces HF hospitalizations and mortality compared to usual care; characterize ethnic differences in the HF syndrome in hospitalized native Hawaiians and Pacific peoples compared to Caucasians; construct HF pedigrees using probands identified at the Queen Emma Clinic for a future HF linkage study in native Hawaiians and Pacific peoples; educate community-based health workers to perform echocardiography scans for the detection of HF in a high risk population of native Hawaiians and Pacific peoples; and train new investigators to conduct research focused on CVD disparities in general, and HF in particular. By achieving these aims, the HFD Program will improve access to HF care at Community Health Centers that serve native Hawaiians and Pacific peoples, fill a gap in knowledge of CVD disparities in native Hawaiians and Pacific peoples, and provide a foundation for future studies on genetic determinants of HF.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Conditions

Cardiovascular Diseases

Location

University of Hawaii at Manoa
Honolulu
Hawaii
United States
96822

Status

Recruiting

Source

National Heart, Lung, and Blood Institute (NHLBI)

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:53:44-0400

Clinical Trials [1317 Associated Clinical Trials listed on BioPortfolio]

Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)

Human immunodeficiency virus (HIV) infection has been associated with a variety of cardiovascular diseases. Even most industrialised countries exhibit a growing and aging population of HIV...

The Effects of Aerobic Exercise in Microvascular Endothelium Function in Patients With Cardiovascular Diseases

This study evaluates the effects of different volumes of aerobic exercise training in cardiovascular parameters of patients with cardiovascular diseases enrolled in a cardiac rehabilitatio...

ARROW:identificAtion of postpRandial biomaRkers tOWards Cardiovascular Prevention

The purpose of this study is to better understand the association between the postprandial biomarker responses after a food challenge with the development of cardiovascular diseases in hea...

Development, Testing, and Validation of A Protocol To Assess Cardiovascular Reactivity in Human Populations

To develop a comprehensive protocol for assessing cardiovascular reactivity to stressors, for use in epidemiological and clinical investigations of cardiovascular diseases in healthy popul...

Cardiovascular Diseases in the Silesian Region in Poland.

The Silesian Cardiovascular Database is an observational study of all patients hospitalized due to cardiovascular diseases. The date include information on the clinical characteristics, tr...

PubMed Articles [11852 Associated PubMed Articles listed on BioPortfolio]

Dietary habits, body image, and health service access related to cardiovascular diseases in rural Zambia: A qualitative study.

Cardiovascular diseases are among the leading causes of mortality and morbidity in sub-Saharan Africa, including Zambia, where cardiovascular diseases account for 8% of the mortality rates. Despite an...

Assessing the awareness of Czechs, age 40+, on the link between lifestyle choices and risk factors for cardiovascular diseases.

Cardiovascular diseases constitute the main cause of disability and premature death worldwide. Those diseases will continue to endanger health unless the public understands clearly and completely whic...

Pharmacological Modulation of Vagal Nerve Activity in Cardiovascular Diseases.

Cardiovascular diseases are life-threatening illnesses with high morbidity and mortality. Suppressed vagal (parasympathetic) activity and increased sympathetic activity are involved in these diseases....

Assessment of the Perceived Relationship Between Healthy Nutrition and Cardiovascular Diseases by the Adult Czech Population.

Cardiovascular diseases constitute one of the main causes of disability and premature death. The basic pathology consists of atherosclerosis. Therefore, influencing risk factors, including nutrition, ...

Danhong Injection in cardiovascular and cerebrovascular diseases: cardiovascular actions, molecular mechanisms, and therapeutic potential.

Cardiovascular and cerebrovascular diseases are the main cause of mortality worldwide, currently with less than optimum therapeutic options. Danhong injection (DHI) is a medicinal preparation based on...

Medical and Biotech [MESH] Definitions

Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Methods and procedures for the diagnosis of diseases or dysfunction of the cardiovascular system or its organs or demonstration of their physiological processes.

Diseases of long duration and generally slow progression. The four main types of noncommunicable diseases are CARDIOVASCULAR DISEASES (e.g., heart attacks and stroke), CANCER, chronic respiratory diseases (e.g., CHRONIC OBSTRUCTIVE PULMONARY DISEASE and ASTHMA) and DIABETES MELLITUS.

Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)

Dental care for patients with chronic diseases. These diseases include chronic cardiovascular, endocrinologic, hematologic, immunologic, neoplastic, and renal diseases. The concept does not include dental care for the mentally or physically disabled which is DENTAL CARE FOR DISABLED.

More From BioPortfolio on "Partnership Programs for Reducing Cardiovascular Disparities in Native Hawaiians"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Searches Linking to this Trial